All Stories

  1. Transcranial magnetic stimulation for patients with exposure therapy resistant obsessive-compulsive disorder: TETRO - a study protocol for a multicenter randomized controlled trial (Preprint)
  2. Montreal Cognitive Assessment (MoCA) Norms for Older Patients with a Depressive Disorder
  3. Exogenous glucocorticoids to improve extinction learning for post-traumatic stress disorder patients with hypothalamic–pituitary–adrenal-axis dysregulation: a study protocol description
  4. Cost-effectiveness of behavioral activation compared to treatment as usual for depressed older adults in primary care: A cluster randomised controlled trial
  5. Age related differences in symptom networks of overall psychological functioning in a sample of patients diagnosed with anxiety, obsessive compulsive disorder, or posttraumatic stress disorder
  6. High Intensive Exposure and Response Prevention in the Treatment of Obsessive-Compulsive Disorder for a 72-year-Old Man
  7. Association Between Personality Traits and Functional Limitations in Older Adults with Affective Disorders: A Cross Sectional Study
  8. Functional improvement by behavioural activation for depressed older adults
  9. Behavioural Activation versus Treatment as Usual for Depressed Older Adults in Primary Care: A Pragmatic Cluster-Randomised Controlled Trial
  10. Impaired action-safety learning and excessive relief during avoidance in patients with anxiety disorders
  11. The relationship between eating disorders and OCD symptom dimensions: An explorative study in a large sample of patients with OCD
  12. The impact of a history of child abuse on cognitive performance: a cross-sectional study in older patients with a depressive, anxiety, or somatic symptom disorder
  13. Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network meta-analysis
  14. Comorbid depression and treatment of anxiety disorders, OCD, and PTSD: Diagnosis versus severity
  15. Impact of childhood trauma on multidimensional frailty in older patients with a unipolar depressive-, anxiety- or somatic symptom disorder
  16. The enhancing effects of testosterone in exposure treatment for social anxiety disorder: a randomized proof-of-concept trial
  17. Development and psychometric evaluation of the Decision Tool Anxiety Disorders, OCD and PTSD (DTAOP): Facilitating the early detection of patients in need of highly specialized care
  18. Psychometric Properties of the Dutch Dimensional Obsessive-Compulsive Scale (DOCS)
  19. How Does Behavioural Activation Work? A Systematic Review of the Evidence on Potential Mediators
  20. Stepped-care versus treatment as usual in panic disorder: A randomized controlled trial
  21. The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder
  22. Childhood trauma and attachment style predict the four-year course of obsessive compulsive disorder: Findings from the Netherlands obsessive compulsive disorder study
  23. Cognitive Remediation Therapy Does Not Enhance Treatment Effect in Obsessive-Compulsive Disorder and Anorexia Nervosa: A Randomized Controlled Trial
  24. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis
  25. Lower versus higher frequency of sessions in starting outpatient mental health care and the risk of a chronic course; a naturalistic cohort study
  26. Study design of the Routine Outcome Monitoring for Geriatric Psychiatry & Science (ROM-GPS) project; a cohort study of older patients with affective disorders referred for specialised geriatric mental health care
  27. Appraisal-based cognitive bias modification in patients with posttraumatic stress disorder: a randomised clinical trial
  28. Cognitive Therapy or Behavioral Activation for Major Depressive Disorder in Dutch Mental Health Care: Pilot Effectiveness and Process Trial
  29. Psychometric Evaluation of the Decision Tool Anxiety Disorders: Facilitating the Early Identification of Patients with an Anxiety Disorder in Need of Highly Specialized Care
  30. Chronic obsessive–compulsive disorder: prognostic factors
  31. Intensive prolonged exposure therapy for chronic PTSD patients following multiple trauma and multiple treatment attempts
  32. Therapist rotation: a novel approach for implementation of trauma-focused treatment in post-traumatic stress disorder
  33. The relationship between cognitions and symptoms in obsessive-compulsive disorder
  34. Behavioural activation by mental health nurses for late-life depression in primary care: a randomized controlled trial
  35. Intensive prolonged exposure treatment for adolescent complex posttraumatic stress disorder: a single-trial design
  36. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders
  37. Anxiety Disorders in Later Life
  38. Cognitive remediation therapy (CRT) as a treatment enhancer of eating disorders and obsessive compulsive disorders: study protocol for a randomized controlled trial
  39. Symptom Reduction Without Remoralization: A Randomized, Waiting-List Controlled Study Aimed at Separating Two Beneficial Psychotherapy Outcome Effects
  40. Anxiety Disorders in Later Life
  41. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder
  42. Angststoornissen bij ouderen
  43. Optimizing the efficacy of exposure in PTSD treatment
  44. Intensive Cognitive-Behavioral Treatment of PTSD: An Overview of Massed Outpatient Treatment Programs
  45. COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER WITH AGORAPHOBIA IN OLDER PEOPLE: A COMPARISON WITH YOUNGER PATIENTS
  46. De DBC-systematiek negeert de weerbarstige klinische praktijk
  47. Therapeutics in Late-Life Anxiety Disorders—An Update
  48. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder
  49. Gastro-intestinal conditions in patients with obsessive compulsive disorder
  50. Stichting Benchmark GGZ creëert een enorme bureaucratie, maar benchmarkt niet!
  51. Cognitive Inflexibility in Obsessive-Compulsive Disorder and Major Depression Is Associated with Distinct Neural Correlates
  52. The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline
  53. A Randomized Placebo-Controlled Trial of d-Cycloserine to Enhance Exposure Therapy for Posttraumatic Stress Disorder
  54. Psychofarmaca en de gz-psycholoog
  55. Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia
  56. Agoraphobic Cognitions in Old and Young Patients with Panic Disorder
  57. Utility of measuring remoralization in addition to symptoms in efficacy research: A preliminary study
  58. A randomized controlled study of paroxetine and cognitive‐behavioural therapy for late‐life panic disorder
  59. Pharmacotherapy for anxiety disorders in later life
  60. Differential frontal–striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive–compulsive disorder
  61. Cognitive behavioural therapy for anxiety disorders in later life
  62. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis
  63. Outcome Prediction of Cognitive Behaviour Therapy for Panic Disorder: Initial Symptom Severity is Predictive for Treatment Outcome, Comorbid Anxiety or Depressive Disorder, Cluster C Personality Disorders and Initial Motivation Are Not
  64. Sertraline Versus Paroxetine in the Treatment of Panic Disorder
  65. Treatment of Trichotillomania With Behavioral Therapy or Fluoxetine
  66. Reduced sensitivity to temazepam in panic disorder
  67. Sertraline versus paroxetine in the treatment of panic disorder: A multinational randomized double-blind 15 week study
  68. A Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Adjunctive Paroxetine in Panic Disorder Patients Unsuccessfully Treated With Cognitive-Behavioral Therapy Alone